Latest data from September 24, 2021
Number of Health Center respondents = 23 (64% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 4,524 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 73.36% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 274 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 64.18% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 25.91% | 35.04% |
| White, Hispanic/Latino Patients | 6.30% | 9.12% |
| Black/African American, Non-Hispanic/Latino Patients | 60.65% | 48.54% |
| Black/African American, Hispanic/Latino Patients | 0.38% | 0.00% |
| Asian Patients3 | 1.28% | 1.46% |
| American Indian/Alaska Native Patients3 | 0.42% | 1.09% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.13% | 0.00% |
| Patients with More than one race3 | 0.24% | 0.00% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 1.95% | 2.55% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 0.57% | 0.36% |
| Unreported/Refused to Report Race and Ethnicity | 2.17% | 1.82% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 987 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 82.26% |
| COVID-19 Immunization Series Completed | 1,555 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 84.66% |
| COVID-19 Immunization Series Additional | 399 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 79.29% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 14.29% | 14.60% | 17.54% |
| White, Hispanic/Latino Patients | 8.11% | 14.53% | 2.51% |
| Black/African American, Non-Hispanic/Latino Patients | 47.42% | 39.36% | 32.83% |
| Black/African American, Hispanic/Latino Patients | 2.03% | 2.38% | 0.50% |
| Asian Patients3 | 2.03% | 1.03% | 0.00% |
| American Indian/Alaska Native Patients3 | 0.20% | 2.06% | 30.58% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.10% | 13.05% | 0.00% |
| Patients with More than one race3 | 2.43% | 3.67% | 0.00% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 3.95% | 4.50% | 0.75% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 1.11% | 1.16% | 0.25% |
| Unreported/Refused to Report Race and Ethnicity | 18.34% | 3.67% | 15.04% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 26.09% |
| 1 to 24 Hours | 30.43% |
| More Than 24 Hours | 39.13% |
| N/A | 4.35% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 4.35% |
| Staffing to administer the vaccine | 60.87% |
| Vaccine confidence | 26.09% |
| Vaccine storage capacity | 4.35% |
| Vaccine supply | 13.04% |
| Other | 26.09% |
| None | 21.74% |
Operations and Staff
| Metrics | Value |
|---|---|
| Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits | 82.39% |
| Average Percent of Health Center Visits Conducted Virtually | 22.39% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 43.48% |
| Number of Mobile Van Sites | 7 |
| Number of Pop-up Clinics | 22 |
| Number of School-Based Vaccination Sites | 7 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 8.70% |
| Refer patients to another organization that provides monoclonal antibody therapies | 47.83% |
| None | 47.83% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 4.35% |
| Patient awareness/education | 13.04% |
| Staffing capacity | 39.13% |
| Therapy administration/onsite logistics | 34.78% |
| Other | 8.70% |
| None | 52.17% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
